LabMedica

Download Mobile App
Recent News Expo Clinical Chem. Molecular Diagnostics Hematology Immunology Microbiology Pathology Technology Industry Focus

Rapid and Automated System Analyzes Kidney Stones

By LabMedica International staff writers
Posted on 12 Oct 2015
Image: A kidney stone being analyzed automatically using Raman spectrosopy (Photo courtesy of Fraunhofer IPM).
Image: A kidney stone being analyzed automatically using Raman spectrosopy (Photo courtesy of Fraunhofer IPM).
A new imaging system for rapid analysis of urinary stones immediately after the surgical procedure can help determine appropriate postoperative care.

Researchers at the Fraunhofer Institute for Physical Measurement Techniques (IPM; Freiburg, Germany) in collaboration with an industrial partner and University Medical Center Freiburg (Germany) are developing a novel Raman spectroscopy diagnostic system for rapid and automated analysis of kidney stones. The system identifies the light spectrum of the examined sample by illuminating it with a laser, identifying the singular characteristic wave spectrum via the 1% of photons reflected back.

The researchers then use computer software to filter out the fluorescent background occurring during Raman spectroscopy. The results are then compared to a spectral database that contains data on the nine pure substances that make up 99% of urinary stones, as determined by examining nearly 160 samples; the results were confirmed by conventional infrared (IR) based analysis in a reference laboratory. Since the device employs relatively inexpensive optical components, and it can work on wet, unprepared samples, the time taken to prepare specimens is substantially reduced.

“The stones previously had to be dried and pulverized prior to analysis. Our system makes this unnecessary. Stone fragments collected during the surgical procedure do not need to be further processed. They can in principle be put directly into the Raman spectrometer for analysis,” explained IPM physician and researcher Arkadiusz Miernik, MD. “Currently there are a few specialized laboratories that can carry out this procedure using large-scale analytical equipment. A compact device suitable for use in a clinical setting and allowing immediate, post interventional automated analysis is not yet available.”

“We advise stone patients to drink plenty of fluids, increase physical activities and lose weight if necessary. Unfortunately this is only a general recommendation,” added Dr. Miernik. “Once the complete system is ready for clinical use, the physician will be able to examine stone samples directly after surgical intervention on his own, thus increasing the quality of patients’ care substantially.”

Kidney stones are often no larger than a grain of rice, yet some can grow to a diameter of several centimeters, causing blockage of the ureters. If it cannot be dissolved chemically, the kidney stone is treated using extracorporeal shock-wave therapy or minimally invasive endoscopic modalities. Many of these patients suffer from disease recurrence and need retreatment, but new stone formation might be reduced by 50% if individualized follow-up care and proper measures are offered to the patient regarding dietary habits or the use of particular medication strategies, based on stone composition.

Related Links:

Fraunhofer Institute for Physical Measurement Techniques 
University Medical Center Freiburg


Gold Member
Quantitative POC Immunoassay Analyzer
EASY READER+
POC Helicobacter Pylori Test Kit
Hepy Urease Test
Gram-Negative Blood Culture Assay
LIAISON PLEX Gram-Negative Blood Culture Assay
Rapid Molecular Testing Device
FlashDetect Flash10

Channels

Molecular Diagnostics

view channel
Image: The diagnostic device can tell how deadly brain tumors respond to treatment from a simple blood test (Photo courtesy of UQ)

Diagnostic Device Predicts Treatment Response for Brain Tumors Via Blood Test

Glioblastoma is one of the deadliest forms of brain cancer, largely because doctors have no reliable way to determine whether treatments are working in real time. Assessing therapeutic response currently... Read more

Immunology

view channel
Image: Circulating tumor cells isolated from blood samples could help guide immunotherapy decisions (Photo courtesy of Shutterstock)

Blood Test Identifies Lung Cancer Patients Who Can Benefit from Immunotherapy Drug

Small cell lung cancer (SCLC) is an aggressive disease with limited treatment options, and even newly approved immunotherapies do not benefit all patients. While immunotherapy can extend survival for some,... Read more

Microbiology

view channel
Image: New evidence suggests that imbalances in the gut microbiome may contribute to the onset and progression of MCI and Alzheimer’s disease (Photo courtesy of Adobe Stock)

Comprehensive Review Identifies Gut Microbiome Signatures Associated With Alzheimer’s Disease

Alzheimer’s disease affects approximately 6.7 million people in the United States and nearly 50 million worldwide, yet early cognitive decline remains difficult to characterize. Increasing evidence suggests... Read more

Technology

view channel
Image: Vitestro has shared a detailed visual explanation of its Autonomous Robotic Phlebotomy Device (photo courtesy of Vitestro)

Robotic Technology Unveiled for Automated Diagnostic Blood Draws

Routine diagnostic blood collection is a high‑volume task that can strain staffing and introduce human‑dependent variability, with downstream implications for sample quality and patient experience.... Read more

Industry

view channel
Image: Roche’s cobas® Mass Spec solution enables fully automated mass spectrometry in routine clinical laboratories (Photo courtesy of Roche)

New Collaboration Brings Automated Mass Spectrometry to Routine Laboratory Testing

Mass spectrometry is a powerful analytical technique that identifies and quantifies molecules based on their mass and electrical charge. Its high selectivity, sensitivity, and accuracy make it indispensable... Read more